Re: Final results of sequential doxorubicin plus gemcitabine and ifosfamide, paclitaxel, and cisplatin chemotherapy in patients with metastatic or locally advanced transitional cell carcinoma of the urothelium

被引：1
|
作者：
Logothetis, Christopher J. [1 ]
Siefker-Radtke, Arlene [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Unit 1374, Dept Genitourinary Med Oncol, Houston, TX 77230 USA
来源：
EUROPEAN UROLOGY | 2010年 / 57卷 / 04期
关键词：
D O I：
10.1016/j.eururo.2010.01.029
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：728 / 729
页数：3
相关论文
共 50 条
  • [41] Neoadjuvant paclitaxel (P), carboplatin (Ca) and gemcitabine (G) in patients with locally advanced transitional cell carcinoma (TCC) of the bladder: A final report.
    Smith, D. C.
    Mackler, N. J.
    Hussain, M. H.
    Dunn, R.
    Montie, J. E.
    Wood, D.
    Lee, C. T.
    Petrylak, D.
    Quinn, D.
    Vaishampayan, U.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 226S - 226S
  • [42] Phase I study of a 3-drug regimen of gemcitabine/cisplatin/pemetrexed in patients with metastatic transitional cell carcinoma of the urothelium
    Thomas E. Hutson
    Svetislava Vukelja
    Daniel Atienza
    Sanjay Awasthi
    Robert Delaune
    Margaret Deutsch
    Philip Y. Dien
    Thomas F. Gregory
    Michael J. Kolodziej
    Joseph J. Muscato
    Robert N. Raju
    Robert L. Ruxer
    Stephanie Mull
    Des Ilegbodu
    Karen Hood
    Steven Nicol
    William Berry
    Investigational New Drugs, 2008, 26 : 151 - 158
  • [43] Phase I study of a 3-drug regimen of gemcitabine/cisplatin/pemetrexed in patients with metastatic transitional cell carcinoma of the urothelium
    Hutson, Thomas E.
    Vukelja, Svetislava
    Atienza, Daniel
    Awasthi, Sanjay
    Delaune, Robert
    Deutsch, Margaret
    Dien, Philip Y.
    Gregory, Thomas F.
    Kolodziej, Michael J.
    Muscato, Joseph J.
    Raju, Robert N.
    Ruxer, Robert L., Jr.
    Mull, Stephanie
    Ilegbodu, Des
    Hood, Karen
    Nicol, Steven
    Berry, William
    INVESTIGATIONAL NEW DRUGS, 2008, 26 (02) : 151 - 158
  • [44] Final results of randomized study of gemcitabine (G) plus cisplatin (P) versus etoposide (E) plus cisplatin in locally advanced or metastatic non small cell lung cancer (NSCLC)
    Bousahba, A., Sr.
    Bereksi-Reguig, F.
    Seghier, F.
    Boukerche, A.
    Dali-Youcef, A.
    Djellali, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [45] A Phase II Study of the Central European Society of Anticancer-Drug Research (CESAR) Group: Results of an Open-Label Study of Gemcitabine plus Cisplatin with or without Concomitant or Sequential Gefitinib in Patients with Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium
    Miller, Kurt
    Morant, Rudolf
    Stenzl, Arnulf
    Zuna, Ivan
    Wirth, Manfred
    UROLOGIA INTERNATIONALIS, 2016, 96 (01) : 5 - 13
  • [46] Sequential combination chemotherapy in patients with advanced nonsmall cell lung carcinoma -: Carboplatin and gemcitabine followed by paclitaxel
    De Castro, J
    Feliu, J
    Casado, E
    Ordoñez, A
    Barón, MG
    CANCER, 2002, 94 (10) : 2797 - 2798
  • [47] Sequential combination chemotherapy in patients with advanced nonsmall cell lung carcinoma - Carboplatin and gemcitabine followed by paclitaxel
    Edelman, MJ
    Gandara, DR
    Lau, DHM
    Lara, P
    Lauder, IJ
    Tracy, D
    CANCER, 2001, 92 (01) : 146 - 152
  • [48] Maintenance chemotherapy with gemcitabine and paclitaxel for M-VAC refractory metastatic transitional cell carcinoma
    Kawai, K
    Oikawa, T
    Sekido, N
    Hinotsu, S
    Hattori, K
    Miyanaga, N
    Shimazui, T
    Akaza, H
    JOURNAL OF UROLOGY, 2005, 173 (04): : 360 - 360
  • [49] Comparison of efficacy of neoadjuvant chemotherapy with gemcitabine plus cisplatin versus docetaxil, cisplatin, plus fluorouracil in locally advanced nasopharyngeal carcinoma
    Rehman, Abdul
    Haider, Ghulam
    Ramchand, Akash
    Anaum
    Khan, Shumaila Nawaz
    Mahar, Faiza
    Mahmood, Raheela
    Saher, Sana
    Khattak, Yasir Rehman
    Aqeel, Muhammad Arsalan
    PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2024, 37 (02) : 377 - 383
  • [50] Impact of paclitaxel, cisplatin, and gemcitabine as first-line chemotherapy in cisplatin-fit and -unfit patients with advanced/metastatic urothelial carcinoma
    Katayama, Satoshi
    Kobayashi, Yasuyuki
    Takamoto, Atsushi
    Edamura, Kohei
    Sadahira, Takuya
    Iwata, Takehiro
    Nishimura, Shingo
    Sako, Tomoko
    Wada, Koichiro
    Araki, Motoo
    Watanabe, Masami
    Watanabe, Toyohiko
    Nasu, Yasutomo
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2021, 39 (10) : 731.e25 - 731.e32
12345